Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002
- PMID: 12437192
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002
Abstract
This report updates CDC's recommendations for using yellow fever vaccine (CDC. Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunizations Practices: MMWR 1990;39[No. RR-6]1-6). The 2002 recommendations include new or updated information regarding 1) reports of yellow fever vaccine-associated viscerotropic disease (previously reported as febrile multiple organ system failure); 2) use ofyellow fever vaccine for pregnant women and persons infected with human immunodeficiency virus (HIV); and 3) concurrent use of yellow fever vaccine with other vaccines. A link to this report and other information related to yellow fever can be accessed at the website for Travelers' Health, Division of Global Migration and Quarantine, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/travel/index.htm, and through the website for the Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/ncidod/ dvbid/yellowfever/index.htm.
Similar articles
-
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27. MMWR Recomm Rep. 2010. PMID: 20671663
-
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):647-50. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26086636 Free PMC article.
-
General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2011 Jan 28;60(2):1-64. MMWR Recomm Rep. 2011. PMID: 21293327
-
Yellow fever: epidemiology and prevention.Clin Infect Dis. 2007 Mar 15;44(6):850-6. doi: 10.1086/511869. Epub 2007 Feb 1. Clin Infect Dis. 2007. PMID: 17304460 Review.
-
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.Lancet Infect Dis. 2011 Aug;11(8):622-32. doi: 10.1016/S1473-3099(11)70147-5. Lancet Infect Dis. 2011. PMID: 21798462 Review.
Cited by
-
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects.Vaccines (Basel). 2022 Feb 27;10(3):372. doi: 10.3390/vaccines10030372. Vaccines (Basel). 2022. PMID: 35335004 Free PMC article. Review.
-
Comprehensive Overview of Vaccination during Pregnancy in Europe.J Pers Med. 2021 Nov 13;11(11):1196. doi: 10.3390/jpm11111196. J Pers Med. 2021. PMID: 34834548 Free PMC article. Review.
-
Serious adverse event: late neurotropic disease associated with yellow fever vaccine.Einstein (Sao Paulo). 2020 Feb 17;18:eRC5041. doi: 10.31744/einstein_journal/2020RC5041. eCollection 2020. Einstein (Sao Paulo). 2020. PMID: 32074223 Free PMC article.
-
STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.Can Commun Dis Rep. 2010 Jun 10;36(ACS-3):1-31. doi: 10.14745/ccdr.v36i00a03. eCollection 2010 Jun 10. Can Commun Dis Rep. 2010. PMID: 31701957 Free PMC article. No abstract available.
-
Statement for Travellers and Yellow Fever: Committee to Advise on Tropical Medicine and Travel.Can Commun Dis Rep. 2010 Oct 2;36(ACS-11):1-23. doi: 10.14745/ccdr.v36i00a11. eCollection 2010 Oct 2. Can Commun Dis Rep. 2010. PMID: 31701949 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical